Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-05-27 @ 8:56 AM
Study NCT ID:
NCT04709458
Status:
UNKNOWN
Last Update Posted:
2022-05-03
First Post:
2021-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis
Sponsor:
Taiga Biotechnologies, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Myelofibrosis | View |
| None | Leukemia | View |
| None | Allogeneic stem cell transplant | View |
| None | Acute Myelogenous Leukemia | View |
| None | Myeloproliferative disorders | View |
| None | Primary myelofibrosis | View |
| None | Bone Marrow Cancer | View |
| None | Bone Marrow Transplant | View |
| None | Acute Myeloid Leukemia | View |